Generated by All in One SEO v5.0.1.1, this is an llms.txt file, used by LLMs to index the site.

# Myopia Institute

## Sitemaps

- [XML Sitemap](https://myopiainstitute.org/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [News](https://myopiainstitute.org/news/)
- [Inauguration of the Hong Kong Myopia Taskforce at APAO Congress 2026](https://myopiainstitute.org/inauguration-of-the-hong-kong-myopia-taskforce-at-apao-congress-2026/) - Professor Serge Resnikoff, Chair of the International Myopia Institute (IMI), attended the inauguration of the Hong Kong Myopia Taskforce on Thursday, 5 February 2026, during the APAO Congress in Hong Kong. He was invited to serve as a Senior Advisor to the Taskforce, reflecting the value placed on international expertise and evidence-based leadership in addressing
- [IMI Participates in the IV Siberian Myopia Conference](https://myopiainstitute.org/imi-participates-in-the-iv-siberian-myopia-conference/) - On December 6-7, Novosibirsk hosted one of the most significant events in the ophthalmology community: the IV Siberian Myopia Conference with International Participation. Specialists gathered to exchange experiences, discuss the latest achievements, and map out future developments in the fight against myopia. Approximately 200 ophthalmologists from 30 cities across Russia, Kazakhstan, Uzbekistan, and other republics
- [IMI Attends the BrightChina 2025 Myopia Prevention and Control Conference](https://myopiainstitute.org/imi-attends-the-brightchina-2025-myopia-prevention-and-control-conference/) - The BrightChina 2025 Myopia Prevention and Control Conference was held from October 24 to 26, 2025, at the Shanghai Fuyue Hotel. The event brought together over 150 domestic and international experts, along with more than 1,500 delegates, to discuss cutting-edge research, clinical practices, and policy strategies in myopia prevention and control. The conference featured 23
- [IMI Release Special Editorial On Myopia Correction, Control And Management Terminology](https://myopiainstitute.org/imi-release-special-editorial-on-myopia-correction-control-and-management-terminology/) - The International Myopia Institute (IMI) is pleased to announce the publication of its latest consensus editorial “Myopia Correction, Myopia Control, and Myopia Management: Definitions and Recommended Usage.” Now available on Open Access in Investigative Ophthalmology & Visual Science (IOVS), this editorial serves as a gateway to the 2025 IMI White Paper series, giving long-needed clarity
- [New OPO Special Issue Highlights Key Debates in Myopia From the International Myopia Conference](https://myopiainstitute.org/new-opo-special-issue-highlights-key-debates-in-myopia-from-the-international-myopia-conference/) - The Ophthalmic & Physiological Optics (OPO) journal has released a special issue featuring Point-Counterpoint articles based on the widely attended International Myopia Institute (IMI) Debates, held at the International Myopia Conference (IMC) in Hainan, China.This special edition presents a unique scholarly format that captures the spirit of the live debates, where leading global experts explored
- [IMI at the International Myopia Conference 2024](https://myopiainstitute.org/imi-at-the-international-myopia-conference-2024/) - The International Myopia Conference was held in Hainan, China, from the 25th to the 28th of September and featured over 1000 attendees from 44 different countries. The IMI 2025 White Paper Presentations and the series of IMI Debates were a great success, with strong engagement from the crowd and a fantastic turnout. A complete recording of the
- [Download: Initial Refractive Assessment Flowchart](https://myopiainstitute.org/initial-refractive-assessment-flowchart/) - Following the publication of Tapasztó et al’s (2023) paper on the myopia management algorithm, the IMI has produced a printable clinical resource for eye care practitioners to use during the primary and secondary prevention of myopia.Download and print the Initial Refractive Assessment Flowchart for reference in clinical settings. Download Flowcharts
- [BRITISH JOURNAL OF OPHTHALMOLOGY REVIEW: MYOPIA CONTROL STRATEGIES RECOMMENDATIONS FROM THE 2018 WHO/IAPB/BHVI MEETING ON MYOPIA](https://myopiainstitute.org/british-journal-of-ophthalmology-review-myopia-control-strategies-recommendations-from-the-2018-who-iapb-bhvi-meeting-on-myopia/) - Myopia is a major public health problem, particularly in East Asia. In this summary report, we present key findings and recommendations on strategies for myopia control discussed during the meeting jointly organised by the WHO Regional Office for the Western Pacific, the International Agency for the Prevention of Blindness and BHVI. Download the paper here.
- [WHO WORLD VISION REPORT](https://myopiainstitute.org/who-world-vision-report/) - Everyone, if they live long enough, will experience at least one eye condition in their lifetime that will require appropriate care. Globally, at least 2.2 billion people have a vision impairment or blindness, of whom at least 1 billion have a vision impairment that could have been prevented or has yet to be addressed. Tens
- [WHO REPORT 2016](https://myopiainstitute.org/who-report-2016/) - In March 2015 the World Health Organization (WHO) held a Global Scientific Meeting on Myopia at the Brien Holden Vision Institute in Sydney, Australia, to address the public health issue of myopia, the classification of myopia, evidence for treatments, and the need to take action. The meeting, which brought together myopia experts from each WHO
- [Greek Translated IMI 2019 & 2021 Reports in 'Modern Optical'](https://myopiainstitute.org/greek-translated-imi-2019-2021-reports-in-modern-optical/) - Our friends at ‘Modern Optical’ (Σύγχρονη Οπτική) have translated the IMI 2019 and IMI 2021 Clinical Summaries into Greek, published in issues 25 and 26 of their opticians magazine.Download the the translations here. Download IMI 2019 Translations Download IMI 2021 Translations
- [World Council of Optometry Hosts Landmark Myopia Management Virtual Event Focused on Latin America](https://myopiainstitute.org/world-council-of-optometry-hosts-landmark-myopia-management-virtual-event-focused-on-latin-america/) - As part of its efforts to further the adoption of myopia management as the standard of care, the World Council of Optometry (WCO), in partnership with CooperVision, presents its first Latin America-based virtual event, “Myopia Management: From Theory to Practice,” February 20, 22, 27, and 29 2024. The virtual event will be held entirely in
- [DUTCH TRANSLATED IMI 2021 CLINICAL SUMMARIES](https://myopiainstitute.org/dutch-translated-imi-2021-clinical-summaries/) - Thank you to Gabi Steenbekkers and platinum sponsor CooperVision for this collated version of dutch clinical summaries translations of the 2021 IMI White Papers. The translations can be found here.
- [IMI 2021 White Papers Reviewed in Franja Visual](https://myopiainstitute.org/imi-2021-white-papers-reviewed-in-franja-visual/) - We want to thank our Ambassadors Edgar Davila-Garcia and Ariolfo Vazquez who are a part of Group Manejo Miopia Latam, for publishing IMI 2021 white paper reviews in Spanish in Franja Visual. You can download the first of the review series here.
- [IMI Ambassadors Join for Myopia Management Symposium in Peru](https://myopiainstitute.org/imi-ambassadors-join-for-myopia-management-symposium-in-peru/) - On the 24th and 25th of November, the Myopia Management Symposium took place in Peru, within the framework of the IX National and International Congress of Optometry and Optical Entrepreneurs COE 2023. The event was organized by the Guild of Optometrists and Optical Entrepreneurs of Peru (GOOP).The IMI maintained a strong presence at the event,
- [The Siberian Centre for the Prevention and Treatment of Myopia participates in World Sight Day](https://myopiainstitute.org/the-siberian-centre-for-the-prevention-and-treatment-of-myopia-participates-in-world-sight-day/) - The Siberian Centre for the Prevention and Treatment of Myopia has again participated in World Sight Day for 2023. This year, a team of specialists worked at the “Warm House” Centre for Helping Children Left Without Parents. All children underwent ophthalmological diagnostics, with prescription glasses selected and presented where necessary to help those with vision impairments. IMI
- [IMI Ambassador Speaks at the Argentinian Congress of Opticianry and Contactology](https://myopiainstitute.org/imi-ambassador-speaks-at-the-argentinian-congress-of-opticianry-and-contactology/) - On the 4th-5th of August 2023, the Argentinian Congress of Opticianry and Contactology took place in Cordoba Argentina. As part of the academic program, a panel on Myopia Control and Management took place. Our Ambassador for LATAM (Puerto Rico), Dr. Edgar Davila-Garcia, participated as part of the panel and also spoke about the IMI and
- [The International Myopia Institute Announces Five New Travel Grants](https://myopiainstitute.org/the-international-myopia-institute-announces-five-new-travel-grants/) - The International Myopia Institute is proud to announce the sponsorship of five new travel grants to be awarded to international early career researchers or students pursuing their PhD/Masters, who have submitted an abstract related to myopia for the Academy 2023 New Orleans meeting. Recipients will be recognised at the AAOF Celebration Luncheon on October 14, 2023. For more information on the grants, visit
- [Argentinian Ambassador María Marta Galána and her team honoured by the Argentinian Council of Ophthalmology with best scientific achievement of 2022](https://myopiainstitute.org/argentinian-ambassador-maria-marta-galana-and-her-team-honoured-by-the-argentinian-council-of-ophthalmology-with-best-scientific-achievement-of-2022/) - Argentinian Ambassador María Marta Galána and her team have been honoured by the Argentinian Council of Ophthalmology with a prestigious award, recognizing the best scientific achievement of 2022. Galána's team, known as the Myopia Study Group of the Argentine Society of Pediatric Ophthalmology, embarked on an extensive research project to establish a consensus on
- [BHVI Launches Myopia Awareness Week 2023](https://myopiainstitute.org/bhvi-launches-myopia-awareness-week-2023/) - Keep your eye on myopia is the message for #MyopiaAwarenessWeek 2023, with a call to ECPs to include myopia treatment as an essential part of their patients’ eye health care. SYDNEY, Australia, May 1, 2023 – We are excited to announce the launch of Myopia Awareness Week for 2023 – a global initiative started in
- [IMI Releases Key White Paper Findings Through Recorded Interviews With White Paper Taskforce Chairs](https://myopiainstitute.org/imi-releases-key-white-paper-findings-through-recorded-interviews-with-white-paper-taskforce-chairs/) - Sydney, Australia, – The International Myopia Institute (IMI) is pleased to announce the release of recorded white paper interviews. Myopia is one of the greatest public health eye issues of the 21st century, with 50% of the world’s population predicted to be affected by 2050. Research on the topic is rapidly evolving which makes it
- [IMI at the 2022 Siberian Myopia Conference](https://myopiainstitute.org/imi-at-the-2022-siberian-myopia-conference/) - Provided by Prof. Irina Smirnova MD, PhD Director of the Siberian Ophthalmological Center “Glazka”, Head of the Siberian Association of Pediatric Ophthalmologists IMI Russia Ambassador On November 19, 2022, the II Siberian Myopia Conference was held in Novosibirsk (Russia) in an offline format with an online broadcast. More than 300 specialists registered for it, and
- [IMI at Bright China 2022](https://myopiainstitute.org/imi-at-bright-china-2022/) - On December 24, 2022, the New Concept · New Height Retina China 2022 and the 2nd Myopia Prevention and Treatment Integration Forum (Bright China 2022) were successfully held online. Forty-three myopia experts worldwide gathered together, focusing on the new concept, new height, and new technology of myopia, to bring the latest perspectives on myopia prevention
- [Update and Guidance on Management of Myopia ticks over 30,000 views](https://myopiainstitute.org/update-and-guidance-on-management-of-myopia-ticks-over-30000-views/) - IMI is pleased to report that our publication developed in cooperation with the European Society of Ophthalmology, 'Update and Guidance on Myopia Management' has been accessed 31,141 times, and has already been cited in 55 articles since publication in the European Journal of Ophthalmology. The European Society of Ophthalmology are also pleased to announce the
- [Reversing the myopia trend: a public health approach](https://myopiainstitute.org/reversing-the-myopia-trend-a-public-health-approach/) - On World Sight Day, EssilorLuxottica hosted a live panel discussion titled 'Reversing the myopia trend: a public health approach', The session was moderated by Olga Prenat, Head, Medical Marketing, Professional Relations and Vision Care Education, EssilorLuxottica, and Prof. Kovin Naidoo, Global Head, Advocacy and Partnerships, OneSight EssilorLuxottica Foundation. Renowned experts from EssilorLuxottica’s partner organizations, Prof.
- [IMI at the 2022 Turkish Republics Opthalmology Meeting](https://myopiainstitute.org/imi-at-the-2022-turkish-republics-opthalmology-meeting/) - A joint meeting of the Turkish Republics Ophthalmology Meeting-Azerbaijan Ophthalmology Society and 14th Azerbaijan Young Ophthalmologists took place in Baku, Azerbaijan between 14th and 15th of October. Ugur Emrah Altiparmak, IMI Ambassador made a presentation about the impact of Myopia today and tomorrow and Myopia Management Modalities to the participants. Ambassador to IMI, Mukharram Bikbov
- [LOSING SIGHT: Inside the Myopia Epidemic Private Screening](https://myopiainstitute.org/losing-sight-inside-the-myopia-epidemic-private-screening/) - A new public awareness film on myopia, Losing Sight – Inside the Myopia Epidemic, created by acclaimed filmmaker Jane Weiner, will be made available to stream online from 30 October to 16 November 2022, with three live panel discussions occurring on 3 November. Having watched the 25-minute work-in-progress film excerpt, audience members will be asked
- [IMI at The National and International Congress of Optometry, Ecuador](https://myopiainstitute.org/imi-at-the-national-and-international-congress-of-optometry-ecuador-2022/) - The National and International Congress of Optometry in Ecuador took place on October 6-8th. IMI Ambassadors from Latin America dedicated an entire module to myopia management. Dr Edgar Davila presented an introductory lecture on myopia management, and, together with Dr Ariolfo Vazquez, conducted a workshop on how to implement orthokeratology for myopia control. Dr Vazquez
- [IMI at the International Myopia Conference 2022, Rotterdam](https://myopiainstitute.org/imi-at-the-international-myopia-conference-2022-rotterdam/) - IMI at the International Myopia Conference 2022, Rotterdam.The IMC conference held 4-7th September, Rotterdam, Netherlands attracted over 700 clinicians and researchers from around the globe. The conference sessions and posters covered an expansive range of topics including myopia prevalence in different parts of the word, experimental and animal models, management strategies, imaging and biometry, risk
- [IMI Early Career Award Winners](https://myopiainstitute.org/imi-early-career-award-winners/) - The International Myopia Institute are pleased to announce the winners of the IMI Early Career Awards for Best Poster and Best Paper at the 2022 International Myopia Conference in Rotterdam, Netherlands. Best Poster Congratulations to Best Poster winner, Gareth Lingham, from Technological University Dublin, for his poster described in "Myopic progression in anisometropic and isometropic eyes:
- [IMI 2022 INTERNATIONAL MYOPIA CONFERENCE TRAVEL GRANT AWARDEES ANNOUNCED](https://myopiainstitute.org/imi-rotterdam-travel-grant-awardees-announced/) - The International Myopia Institute are pleased to announce the recipients of IMI Travel Grants to the 2022 International Myopia Conference in Rotterdam, Netherlands.The recipients are: Patricia Ioschpe Gus Brazil, Universidade Federal do Rio Grande do Sul Dr. Patrícia Ioschpe Gus, MD, phD is a Brazilian ophthalmologist specialized in refractive surgery, contact lenses and keratoconus. Patrícia
- [Global practitioner survey on myopia management uptake](https://myopiainstitute.org/global-practitioner-survey-on-myopia-management-uptake/) - The International Myopia Institute (IMI) is currently conducting a global practitioner survey on myopia management uptake. The survey was conducted previously in 2015 and 2019 and was published in the Contact Lens and Anterior Eye journal. IMI is planning a new publication with updated results and have secured publication from IOVS for a special 2023
- [Turkey IMI Ambassador Prof. Dr. U. Emrah Altıparmak in SABAH](https://myopiainstitute.org/turkey-imi-ambassador-prof-dr-u-emrah-altiparmak-in-sabah/) - The Covid-19 pandemic is over. However, home restrictions in the difficult process increased eye disorders, especially in children. Digital addiction continued after the pandemic. According to WHO, the number of people who are nearsighted, that is, farsighted, has increased by 33 percent. SABAH asked the experts, "What is the solution to this problem?" Here are
- [Turkish IMI Ambassador Prof. Dr. U. Emrah Altıparmak in "Actual Medicine"](https://myopiainstitute.org/turkish-imi-ambassador-prof-dr-u-emrah-altiparmak-in-actual-medicine/) - Turkish IMI Ambassador Prof. Dr. U. Emrah Altıparmak is interviewed by Turkish medical magazine Actual Medicine, discussing the purpose of IMI, Myopia Awareness Week, and emphasizing on the growing impact of myopia. As appeared in Volume: 30, Issue: 2, 2022. Turkish Bu sene 2328 Mayıs olarak belirlenen “Miyopi Farkındalık Haf ta sı”nda çeşitli etkinlikler düzenlenmekte. Miyopi
- [#MyopiaAwarenessWeek with IMI ambassador Mukharram Bikbov & Ufa Eye Research Institute](https://myopiainstitute.org/myopiaawarenessweek-with-imi-ambassador-mukharram-bikbov-ufa-eye-research-institute/) - On May 22, as part of BHVI's ‘Myopia Awareness Week’ (May 23 - May 28), Ufa Eye Research Institute (Ufa, Russia) held a sports event under the slogan “The sun loves us!” for patients, children and adolescents with myopia and their parents. The event's purpose was to bring attention to the increasing number of myopia
- [Myopia Awareness Week 2022 - Make Your Eye Moves!](https://myopiainstitute.org/myopia-awareness-week-2022-make-your-eye-moves/) - BHVI, an Australian not-for-profit organization with an international focus on vision research, has announced the launch of Myopia Awareness Week for 2022 - a global initiative relaunched in 2021, to bring attention to the growing epidemic of myopia in children across the world. Myopia, also known as nearsightedness, is among the most common ocular disorders
- [WCO Myopia Management Webinar](https://myopiainstitute.org/wco-myopia-management-webinar/) - When: Wednesday January 27, 2021 Time: 8:00 AM to 9:30 AM CST Where: Recorded, Online AboutIMI Executive Director Dr Monica Jong and Taskforce Leader Professor Ian Flitcroft, along with committee members Dr Maria Liu and Dr Fuensanta Vera-Diaz, and fellow panellists Indie Grewal and Matt Oerding, recently participated in an expert panel discussion on myopia
- [International Myopia Conference 2022](https://myopiainstitute.org/international-myopia-conference-2022-chaired-by-prof-caroline-klaver/) - When: 4th – 7th September, 2022 Where: Rotterdam, The Netherlands Registration: internationalmyopiaconference.org Google Calendar ICAL/Outlook Abstract submission deadline extension for the 2022 International Myopia Conference From September 4-7, 2022, the 18th International Myopia Conference will be held in Rotterdam, the Netherlands. This is the largest international myopia convention, bringing together vision and basic scientists, clinical
- [Abstract submission deadline extension for the 2022 International Myopia Conference](https://myopiainstitute.org/abstract-submission-deadline-extension-for-the-2022-international-myopia-conference/) - From September 4-7, 2022, the 18th International Myopia Conference will be held in Rotterdam, the Netherlands. This is the largest international myopia convention, bringing together vision and basic scientists, clinical experts, as well as policy makers. It will incorporate research from bench to bedside and will answer all your questions on myopia control and new
- [IMI at the 2021 Philippine College of Optometrists](https://myopiainstitute.org/imi-at-the-philippine-college-of-optometrists/) - Over 600 Philippine eyecare professionals attended the Philippine College of Optometrists (PCO) annual general meeting held online on 28th November to learn about the resource available for myopia management from IMI. Rebecca Weng, Project Director of the IMI, delivered the session from Sydney, introducing the IMI and the growing body of research provided by IMI’s
- [IMI at the 2021 Pan American Congress of Optometry](https://myopiainstitute.org/imi-at-the-2021-pan-american-congress-of-optometry/) - The Pan American Congress of Optometry held on 25-27th November attracted over 400 eyecare practitioners across Mexico, Central and South America attending in person. Our Colombia ambassador Dr Luisa Casas Luque presented the challenges faced by optometrists in managing myopia and receiving positive responses to her presentation. The attendees were eager to get their hand
- [IMI at the 2021 Mackay Annual Optometry Virtual Conference](https://myopiainstitute.org/imi-at-the-2021-mackay-annual-optometry-virtual-conference/) - The 2021 Mackay Annual Optometry Virtual Conference held on 21st November in Taiwan, had close to 200 eye care practitioners attend online. The theme of the conference was ‘Latest Development and Technology Advancement in Optometry’. Rebecca Weng, Project Director of IMI presented the ‘Latest Development and Technology Advancement in Optometry’ and introduced IMI and the
- [IMI White Papers in top ten achievements in 2021 eyecare sector](https://myopiainstitute.org/imi-white-papers-in-top-ten-achievements-in-2021-eyecare-sector/) - IMI’s second series of White Papers are one of the top ten most mind-blowing achievements in the 2021 eyecare sector, on several Chinese social media platforms. The second series of IMI White Papers was released last April and has further cemented the IMI’s leadership role in producing evidence-based research findings in the myopia field. Click
- [Launch of the WHO-ITU Be He@lthy, Be Mobile toolkit for myopia (mMyopia)](https://myopiainstitute.org/launch-of-the-who-itu-be-helthy-be-mobile-toolkit-for-myopia-mmyopia/) - Join us on Mar 15, 2022 12:00 PM (GMT+1) to hear about the mMyopia mobile toolkit developed by the World Health Organization and the International Telecommunication Union. This toolkit includes evidence-based message libraries for key end-user groups, along with operational guidance and resources for adapting, implementing and monitoring the mMyopia programme. The toolkit is intended
- [JAMA Ophthalmology publishes two-year clinical trial results of Essilor’s Stellest™ lens](https://myopiainstitute.org/jama-ophthalmology-publishes-two-year-clinical-trial-results-of-essilors-stellest-lens/) - Study provides conclusive evidence of effectiveness of the lens in second year Charenton, 01 April, 2022 – The two-year clinical trial results of Essilor Stellest™ lenses were today in the prestigious medical journal, JAMA Ophthalmology. Essilor Stellest™ lenses continue to demonstrate strong myopia control efficacy after two years. The children in the clinical trial
- [Mastering Myopia Interview with IMI Project Director Rebecca Weng](https://myopiainstitute.org/mastering-myopia-interview-with-imi-project-director-rebecca-weng/) - IMI Project Director Rebecca Weng was recently interviewed by Professor Mark Bullimore in Mastering Myopia, a Global Myopia Symposium newsletter. In this interview, Rebecca and Mark discuss what's next for the IMI, with Mark being a task force chair for ‘Adult myopia’ in our upcoming 2023 IMI White Paper series.
- [INTERNATIONAL MYOPIA INSTITUTE WELCOMES HOYA VISION CARE  TO JOIN IN RAISING MYOPIA AWARENESS AND PROMOTING EVIDENCE-BASED MYOPIA MANAGEMENT](https://myopiainstitute.org/international-myopia-institute-welcomes-hoya-vision-care-to-join-in-raising-myopia-awareness-and-promoting-evidence-based-myopia-management/) - The International Myopia Institute (IMI) is pleased to announce HOYA Vision Care, a leader in optical technology innovation, has announced their support of IMI activities to promote advocacy, advance research, and educational efforts in the global fight to address and manage myopia to prevent future vision impairment and blindness. “IMI welcomes Hoya onboard, there still
- [IMI BEGINS ROLLING OUT A GLOBAL PRACTITIONER SURVEY ON MYOPIA MANAGEMENT](https://myopiainstitute.org/imi-begins-rolling-out-a-global-practitioner-survey-on-myopia-management/) - Sydney, Australia, March 31, 2021 – The International Myopia Institute (IMI) is pleased to announce the launch of a global practitioner survey on myopia management uptake. The International Myopia Institute (IMI) has developed key evidence-based resources that can be used by eye care practitioners to implement the best myopia management practices. While there has been
- [INTERNATIONAL MYOPIA INSTITUTE RELEASES NEW IMI CLINICAL SUMMARIES](https://myopiainstitute.org/international-myopia-institute-releases-new-imi-clinical-summaries/) - Sydney, Australia, July 15, 2021 – The International Myopia Institute (IMI) is pleased to announce the release of the 2021 IMI White Papers Clinical Summaries in English and other languages.The IMI recently published the highly anticipated second volume of the 2021 IMI White Papers and yearly digest in a special issue of the peer-reviewed Investigative
- [IMI Turkey Ambassador Dr Emrah Altiparmak at Alcon Excellence Academy 2021](https://myopiainstitute.org/imi-turkey-ambassador-dr-emrah-altiparmak-at-alcon-excellence-academy-2021/) - Our Turkish ambassador, Dr Emrah Altiparmak was invited to present at the Alcon Excellence Academy that took place on the 19th of December in Ankara, Turkey. The event attracted over 100 ophthalmologists to attend in person and Dr Altiparmak’s talk on myopia and its impact aroused a great interest in the audience and it is
- [IMI represented at Conference on Updates in Contact Lens and Ophthalmic Optic in Italy](https://myopiainstitute.org/imi-represented-at-conference-on-updates-in-contact-lens-and-ophthalmic-optic-in-italy/) - The thirteenth “Conference on updates in Contact lens and Ophthalmic Optic” held on 3-4th October 2021 in Monopoli (BA), Italy, had more than 400 eye care practitioners show up in person at the event. A dedicated session on myopia was held during the conference with presenters from both optometry and ophthalmology backgrounds, working in synergy
- [IMI at the Siberian Myopia Conference](https://myopiainstitute.org/imi-at-the-siberian-myopia-conference/) - The Siberian Myopia Conference held on 25th Oct attracted over 100 leading paediatric ophthalmologists attending in person and over 1000 viewers online. This inaugural event marked a great beginning of raising myopia management awareness in Russia. Our Russian ambassador Dr Irina Smirnova, Director of Ophthalmological Centres of Eye, Head of the Siberian Association of Paediatric
- [Virtual EYE2EYE Series: Proactively Managing the Childhood Myopia Pandemic](https://myopiainstitute.org/virtual-eye2eye-series-proactively-managing-the-childhood-myopia-pandemic/) - The growing prevalence of childhood myopia mandates that eye care practitioners have a thorough understanding of managing myopia proactively. This panel discussion covers available and future interventions for controlling myopia progression, evidence supporting their use in clinical practice, and current preferred practice guidelines. Specific questions to be addressed include: Who to treat? When to treat?
- [IMI LAUNCHES INFOGRAPHIC FOR PRACTITIONERS](https://myopiainstitute.org/imi-launches-infographic-for-practitioners/) - Sydney, Australia, 25 August 2021 – The International Myopia Institute (IMI) has developed the IMI Facts and Findings Infographic for practitioners based on the IMI White Papers published in 2019 and 2021. The IMI Facts and Findings Infographic will create more awareness about myopia as a public health issue while providing a useful chairside reference
- [CooperVision’s Brilliant Futures™ Myopia Management Program Expands Globally](https://myopiainstitute.org/coopervisions-brilliant-futures-myopia-management-program-expands-globally/) - Following U.S. Success, CooperVision’s Brilliant Futures™ Myopia Management Program Expands Globally UK, Russia, Spain, Portugal, Canada, South Korea and Taiwan Adopt the Comprehensive Approach SAN RAMON, Calif., November 10, 2020—Less than a year after debuting its Brilliant Futures™Myopia Management Program featuring the MiSight® 1 day contact lens in the United States, CooperVision is now
- [International Myopia Institute Welcomes Oculus To Join In Tackling Myopia Awareness](https://myopiainstitute.org/international-myopia-institute-welcomes-oculus-to-join-in-tackling-myopia-awareness/) - Sydney, Australia, July 21, 2021 – The International Myopia Institute (IMI) is pleased to announce that German ophthalmic medical device manufacturer, OCULUS, has announced their support of IMI activities to advance the research and awareness of myopia to prevent future vision impairment and blindness.“We are thrilled to have OCULUS join in our mission to advance
- [IMI Announces New Chief Scientist](https://myopiainstitute.org/imi-announces-new-chief-scientist/) - Thursday, 26 June 2021, Sydney, Australia – The International Myopia Institute (IMI) announced today that Professor James Wolffsohn has accepted the position of Chief Scientist of IMI, following the retirement of Professor Earl L. Smith from the role. Professor Smith is renowned for his ground-breaking research in myopia, in particular emmetropization and refractive development in
- [Open Access: The Risks and Benefits of Myopia Control](https://myopiainstitute.org/open-access-the-risks-and-benefits-of-myopia-control/) - AbstractPurposeThe prevalence of myopia is increasing around the world, stimulating interest in methods to slow its progression. The primary justification for slowing myopia progression is to reduce the risk of vision loss through sight-threatening ocular pathologic features in later life. The article analyzes whether the potential benefits of slowing myopia progression by 1 diopter (D) justify the potential risks
- [Essilor Supports IMI’s Highly-Awaited 2021 Series Of White Papers On Myopia](https://myopiainstitute.org/essilor-supports-imis-highly-awaited-2021-series-of-white-papers-on-myopia/) - The new white papers have been authored by leading global experts in myopia, and cover key topics such as pathologic myopia, impact of myopia, risk factors for myopia, accommodation and binocular vision in myopia development and progression, and prevention of myopia and its progression. As myopia research and interventions continue to advance, the new white
- [Reducing the Global Burden of Myopia by Delaying the Onset of Myopia and Reducing Myopic Progression in Children](https://myopiainstitute.org/reducing-the-global-burden-of-myopia-by-delaying-the-onset-of-myopia-and-reducing-myopic-progression-in-children/) - IntroductionIn 2019, the American Academy of Ophthalmology (AAO) created the Task Force on Myopia in recognition of the substantial global increases in myopia prevalence and its associated complications. The Task Force, led by Richard L. Abbott, MD, and Donald Tan, MD, comprised recognized experts in myopia prevention and treatment, public health experts from around the
- [IMI WELCOMES BHVI MYOPIA AWARENESS WEEK](https://myopiainstitute.org/imi-welcomes-bhvi-myopia-awareness-week/) - Tuesday 25th May, Sydney, Australia – The International Myopia Institute (IMI) welcomes the relaunch of Myopia Awareness Week, from May 24 – 28, 2021, supporting this important global initiative of BHVI. “There remains much to do in terms of myopia awareness. In many parts of the world, practitioners as well as the general public do
- [WCO and GMAC Support BHVI Myopia Awareness Week 2021](https://myopiainstitute.org/wco-and-gmac-support-bhvi-myopia-awareness-week-2021/) - The World Council of Optometry (WCO) and Global Myopia Awareness Coalition (GMAC) are excited to announce their support of the Brien Holden Vision Institute (BHVI) Myopia Awareness Week, May 24-28, 2021. This global initiative is aimed to bring attention to the growing epidemic of myopia in children across the world.“Myopia is arguably the most widespread
- [New results on Essilor Stellest™ lens to be presented at ARVO 2021](https://myopiainstitute.org/new-results-on-essilor-stellest-lens-to-be-presented-at-arvo-2021/) - (Charenton-le-Pont, 9 April, 2021) – Essilor will unveil the pivotal two-year clinical trial results of its Stellest™ lens – its latest breakthrough spectacle lens solution in the fight against myopia. The much-anticipated two-year results demonstrate that Essilor Stellest™ lenses slow down myopia progression by 67% on average, when compared to single vision lenses, when worn
- [IMI featured in Chinese Eye Care](https://myopiainstitute.org/imi-featured-in-chinese-eye-care/) - The recently published IMI2 White Papers featured in a special edition of IOVS are reaching audiences across the globe, with Chinese Eye Care recently sharing and discussing these important papers online. These white papers included four scholars from mainland China, Professor Mingguang He (Sun Yat-sen University Eye Center/University of Melbourne), Professor Zou Haidong, Professor He Xiangui
- [Essilor Stellest™ spectacle lens receives FDA "Breakthrough Device" designation](https://myopiainstitute.org/essilor-stellest-spectacle-lens-receives-fda-breakthrough-device-designation/) - Essilor has announced that the U.S. Food and Drug Administration (FDA) has granted “Breakthrough Device” designation to its Essilor Stellest™ spectacle lens, a new generation lens developed to correct myopia and slow down the progression of myopia in children. The designation of the Essilor’s Stellest™ spectacle lens as a “Breakthrough Device” by the FDA, that will
- [Why Nearsightedness is on the Rise in Children](https://myopiainstitute.org/why-nearsightedness-is-on-the-rise-in-children/) - Look and you shall see, writes Jane Brody of the New York Times. A generation of the real-life nearsighted Mr. Magoos is growing up before your eyes. A largely unrecognized epidemic of nearsightedness, or myopia, is afflicting the eyes of children. Following IMI Chair Professor Caroline Klaver’s JAMA Ophthalmology article declaring “2020 as the Year of Quarantine
- [32,000 ECPs Tune In To Learn About IMI At The Chinese Opticians Summit](https://myopiainstitute.org/32000-ecps-tune-in-to-learn-about-imi-at-the-chinese-opticians-summit/) - Close to 32,000 Chinese eye care professionals tuned in to the live streamed Chinese Optician's Summit last Friday, to learn about the IMI's global efforts in the area of myopia management and advocacy.
- [World Council of Optometry Passes Resolution Calling for a Standard of Care for Myopia Management](https://myopiainstitute.org/world-council-of-optometry-passes-resolution-calling-for-a-standard-of-care-for-myopia-management/) - The World Council of Optometry (WCO) Board of Directors have approved a resolution providing recommendations for the standard of care for myopia management by optometrists. The resolution defines evidence-based standard of care as comprising of: Mitigation - optometrists educating and counselling parents and children, during early and regular eye exams, on lifestyle, dietary, and other
- [INTERNATIONAL MYOPIA INSTITUTE RELEASES 2021 WHITEPAPERS IN SPECIAL EDITION OF IOVS](https://myopiainstitute.org/international-myopia-institute-releases-2021-whitepapers-in-special-edition-of-iovs/) - 29 April 2021, Sydney, Australia – The International Myopia Institute (IMI) announced today that the much-anticipated 2021 edition of white papers and yearly digest have been released in a special issue of the peer-reviewed Investigative Ophthalmology and Visual Science (IOVS) journal. Continuing the advancement of myopia diagnosis, treatment, prevention, and public awareness, the 2021 white papers follow
- [Review: Myopia control strategies recommendations from the 2018 WHO/IAPB/BHVI Meeting on Myopia](https://myopiainstitute.org/review-myopia-control-strategies-recommendations-from-the-2018-who-iapb-bhvi-meeting-on-myopia/) - AbstractMyopia is a major public health problem, particularly in East Asia. In this summary report, we present key findings and recommendations on strategies for myopia control discussed during the meeting jointly organised by the WHO Regional Office for the Western Pacific, the International Agency for the Prevention of Blindness and the Brien Holden Vision Institute.First,
- [IMI launches campaign for country representatives to build global knowledge base with peers](https://myopiainstitute.org/imi-launches-campaign-for-country-representatives-to-build-global-knowledge-base-with-peers/) - The International Myopia Institute (IMI) consensus group, which brings together clinical researchers, scientists and eye care practitioners advancing myopia research, education and advocacy, is leading a search for eye care practitioners to “help disseminate the evidence from their published white papers to every part of the world.”
- [IMI launches global search for country representatives to lead dissemination of important myopia management information](https://myopiainstitute.org/imi-launches-global-search-for-country-representatives-to-lead-dissemination-of-important-myopia-management-information/) - During the past few months, the group has re-focused our efforts to ensure that we can deliver planned consensus reports early next year, to support eye care practitioners globally.
- [IMI Announces The Next Consensus Reports Will Be Published, Early 2021](https://myopiainstitute.org/imi-announces-the-next-consensus-reports-will-be-published-early-2021/) - The IMI recognises that it is a difficult time for all, and many members have been impacted during COVID-19. Over the past few months, the group has re-focused efforts to ensure that we can deliver planned consensus reports early 2021.
- [Accommodation errors in myopia and the impact of myopia slowing treatments](https://myopiainstitute.org/369/) - Based on the ideas published in: Schmid KL, Strang NC. Differences in the accommodation stimulus response curves of adult myopes and emmetropes: A summary and update. Ophthal Physiol Opt 2015; 35(6), pp. 613-621.
- [Does auditory feedback influence accommodation variability?](https://myopiainstitute.org/does-auditory-feedback-influence-accommodation-variability/) - Poster presentation at International Myopia Conference 2017, Birmingham, UK - Sandra Wagner1, Arne Ohlendorf1,2, Frank Schaeffel3, Siegfried Wahl1,2
- [Global evidence-based effort makes inroads into improving clinical myopia management](https://myopiainstitute.org/global-evidence-based-effort-makes-inroads-into-improving-clinical-myopia-management/) - Olga Prenat, Global Director of Education and Professional Relations at Essilor International and Chief Editor of Points de Vue, recently invited myopia experts, IMI chair Prof. Serge Resnikoff, and committee members Prof. Ian Flitcroft, Prof. Earl Smith and Dr. Monica Jong to share their inspiring journey with the initiative and discuss how the white papers are critical to improving clinical myopia management.
- [Emmetropes and Myopes Differ Little in Their Accommodation Dynamics but Strongly in Their Ciliary Muscle Morphology](https://myopiainstitute.org/emmetropes-and-myopes-differ-little-in-their-accommodation-dynamics-but-strongly-in-their-ciliary-muscle-morphology/) - Presentation at International Myopia Conference Tokyo 2019: Sandra Wagner1, Eberhart Zrenner1,2, Torsten Straßer1
- [Research Review: Update and Guidance on Management of Myopia](https://myopiainstitute.org/research-review-update-and-guidance-on-management-of-myopia/) - By Dwight Akerman, OD, MBA, FAAODue to the urgency of the increasing prevalence of myopia worldwide, the European Society of Ophthalmology, in cooperation with the International Myopia Institute, published a review article to increase awareness among eye care professionals and provide recommendations to prevent the development and progression of myopia in children and adolescents.Based on
- [The International Myopia Institute And The European Society Of Ophthalmology Release New Guidance On Myopia Management.](https://myopiainstitute.org/the-international-myopia-institute-and-the-european-society-of-ophthalmology-release-new-guidance-on-myopia-management/) - 5th March 2021, Budapest, Hungary – The European Society of Ophthalmology (SOE), in collaboration with specialist experts in myopia management, the International Myopia Institute (IMI), has released updated guidance on myopia management to drive European awareness of the debilitating ocular condition.Predicted to become the most common cause of irreversible vision impairment and blindness worldwide and
- [The World Council of Optometry and CooperVision Partner to Define and Promote a Standard of Care to Treat Myopia Progression](https://myopiainstitute.org/the-world-council-of-optometry-and-coopervision-partner-to-define-and-promote-a-standard-of-care-to-treat-myopia-progression/) - ST. LOUIS, March 17, 2021—The World Council of Optometry (WCO) and CooperVision have announced a global partnership to raise awareness of myopia progression and encourage optometrists to embrace a standard of care to manage the condition. “Myopia is arguably the most widespread epidemic faced by the global optometry community. Yet despite the increased prevalence and
- [Contact Lens Evidence-Based Academic Reports (CLEAR)](https://myopiainstitute.org/contact-lens-evidence-based-academic-reports-clear/) - CLEAR, a collaboration of experts including IMI Chair's James Wolffsohn, Lyndon Jones, and member Kathryn Richdale, has released their first reports that critically review, synthesise and summarise the research evidence on contact lenses to date; serving to inform both clinical practice, manufacturing innovation and future research directions. The CLEAR Reports can be accessed here: https://www.sciencedirect.com/science/article/pii/S1367048421000254
- [Dr Monica Jong discusses myopia management - Vision Impact Institute](https://myopiainstitute.org/dr-monica-jong-discusses-myopia-management-vision-impact-institute/) - IMI Executive Director Dr Monica Jong joins Andrea Kirsten of Vision Impact Institute to discuss myopia management, delving into important areas of advocacy, myopia in education, how we should be looking at myopia treatment and the IMI's whitepapers and future efforts. Read the full interview here: https://visionimpactinstitute.org/myopia-management-is-key-to-a-future-of-good-vision-for-children/
- [One-year myopia control efficacy of spectacle lenses with aspherical lenslets](https://myopiainstitute.org/one-year-myopia-control-efficacy-of-spectacle-lenses-with-aspherical-lenslets/) - New research recently published in the British Journal of Ophthalmology finds another potential myopia optical intervention.Researchers from the Wenzhou Medical University, China, found, after one year, spectacle lenses with aspherical lenslets effectively slow myopia progression and axial elongation compared with single-vision spectacle lenses. Myopia control efficacy is also increased with lenslet asphericity.Full, open access article
- [Mivision: International Myopia Institute Delivers New White Papers](https://myopiainstitute.org/mivision-international-myopia-institute-delivers-new-white-papers/) - As we move closer to the anticipated release of the International Myopia Institute second series of whitepapers, IMI Executive Director Dr Monica Jong and BHVI’s and IMI Taskforce Chair Professor Padmaja Sankaridurg were recently interviewed by mivision, to discuss IMI’s ground-breaking reports. The discussion covers the development of IMI2 and impact of COVID-19, the measure of
- [Topically Applied Caffeine, a Non-Selective Adenosine Receptor Antagonist, Alters Emmetropizing Responses in Infant Monkeys.](https://myopiainstitute.org/topically-applied-caffeine-a-non-selective-adenosine-receptor-antagonist-alters-emmetropizing-responses-in-infant-monkeys/) - Poster presentation at International Myopia Conference 2017, Birmingham, UK - Baskar Arumugam1, Li-Fang Hung1, Monica Jong2,3, Lisa Ostrin1, and Earl L Smith III1,2

## Pages

- [Home](https://myopiainstitute.org/) - Advancing myopia research and education to prevent future blindness. Founded by BHVI.
- [Resources](https://myopiainstitute.org/resources/) - IMI Facts and Findings Infographic The IMI Facts and Findings Infographic is a useful public health communication tool and chairside reference of key myopia management evidence-based information easily accessed by practitioners. Download Infographic Translations English Português Svenska Nederlands Pусский Deutsch Español عربي Français Ελληνικά Türkçe Tiếng Việt 汉语 漢語 Italiano עִברִית 日本語 Initial Refractive Assessment Flowchart Download
- [IMI White Papers & Clinical Summaries](https://myopiainstitute.org/imi-white-papers-clinical-summaries/) - Starting with a World Health Organization (WHO) global scientific meeting on myopia at BHVI, Sydney in 2015, the International Myopia Institute was then formed to continue the efforts of the meeting and address the challenges of myopia and high myopia.Full IMI White Papers and translated IMI Clinical Summaries are available below. IMI White Paper Taskforce
- [Taskforces](https://myopiainstitute.org/taskforces/) - Advisory Panel Professor Serge Resnikoff, PhD, MDChair, International Myopia InstituteConjoint Professor, University of New South WalesChair, Our Children’s VisionPresident & Chair, Organisation pour la Prévention de la Cécité Dr Nina Tahhan, PhD, MPH, GradCertOcTher, BOptom(hons)Executive Director, International Myopia InstituteDirector of Clinical Research, Brien Holden Vision InstituteSenior Conjoint Lecturer, School of Optometry and Vision Science, University
- [Membership](https://myopiainstitute.org/membership/) - Become a member Be part of a global collaboration of scientists, clinician and industry professionals wanting to make a difference for the individual patient, and the world, by preventing future sight threatening complications associated with myopia, based on the latest scientific research. Membership is free and includes: Access to the latest knowledge hot off the
- [Myopia](https://myopiainstitute.org/myopia/) - What is myopia? “A refractive error in which rays of light entering the eye parallel to the optic axis are brought to a focus in front of the retina when ocular accommodation is relaxed. This usually results from the eyeball being too long from front to back, but can be caused by an overly curved
- [Membership Application Received](https://myopiainstitute.org/membership-application-received/) - Application Received Thank you for your application to join the International Myopia Institute.Your application has been received and will be reviewed. Return Home
- [Sponsors](https://myopiainstitute.org/sponsors/) - platinum Sponsors silver Sponsor Thank you to our sponsors for their generous support to enable International Myopia Institute to make its resources freely available in many languages. If your organisation is interested in sponsoring International Myopia Institute, please contact us. Founded by
- [IMI Taskforce Interviews](https://myopiainstitute.org/imi-taskforce-interviews/) - Message from the chair of THE imi The mission of the International Myopia Institute is to advance research, patient management and education in myopia to prevent future vision impairment and blindness associated with increasing myopia. We aim to do this by bringing together, but not limited to scientists, clinicians, policy makers, government and educators into
- [Submission Success](https://myopiainstitute.org/submission-success/) - Your submission was successful The form was submitted successfully. Thank you for you for becoming a member of the International Myopia Institute. Please ensure you add imi@bhvi.org to your safe sender list, in order to receive member communications.You may return to the home page or exit the website. Return
- [IMI 2021 ARVO MEETING](https://myopiainstitute.org/imi-2021-arvo-meeting/) - A recording of the first meeting introducing the key findings of the IMI 2021 White Papers at the ARVO 2021 May Virtual Meeting, with a focussed panel discussion on what the implications are for clinical practice and myopia research.IMI 2021 taskforces leaders Professors Kyoko Ohno-Matsui, Jost B. Jonas, Padmaja Sankaridurg, Nicola Logan and Ian Morgan discussed
- [Grants](https://myopiainstitute.org/grants/) - Apply for an IMI Early Career Research Grant The International Myopia Institute is committed to the continued development and advancement of research, patient management and education in myopia, to prevent future vision impairment and blindness associated with increasing myopia. Research grants are available through the IMI, to support early career researchers and students requiring financial
- [Terms & Conditions](https://myopiainstitute.org/terms-conditions/) - The Terms of Use explain the Terms & Conditions of our site. Brien Holden Vision Institute (ABN 49 081 303 282) (“the Institute”) and Brien Holden Vision Institute Foundation (ABN 86 081 872 586) (“the Foundation”), between them, control and operate the website whose home page is at www.myopiainstitute.org (the “Website”). Each reference in these
- [Privacy Policy](https://myopiainstitute.org/privacy-policy/) - This Privacy Statement is a summary of our Privacy Policy and aims to inform you about our collection, use, disclosure and storage of your personal information. At the Brien Holden Vision Institute ABN 49 081 303 282 (the ‘Institute’) and the Brien Holden Vision Institute Foundation ABN 86 081 872 586 (the ‘Foundation’) we take

## IMI Whitepapers

- [IMI Myopia Correction, Myopia Control and Myopia Management: Definitions and Recommended Usage](https://myopiainstitute.org/imi-whitepaper/imi-myopia-correction-myopia-control-and-myopia-management-definitions-and-recommended-usage/) - The terms “myopia management” and “myopia control” are frequently used in both eye care and research settings, sometimes interchangeably, leading to potential confusion. Although both terms are important and useful in different situations, they represent fundamentally distinct concepts. When using such terms, it is important to consider the context and application—for example, whether they are
- [IMI Interventions for Controlling Myopia Onset and Progression 2025](https://myopiainstitute.org/imi-whitepaper/imi-interventions-for-controlling-myopia-onset-and-progression-2025/) - Introduction The recognition of myopia as a significant public health problem has driven the development and evaluation of numerous interventions to slow its progression and delay its onset, particularly since the International Myopia Institute’s 2019 review.1 This new 2025 article2 reviews the efficacy of such interventions. In summarizing the efficacy of mature technologies, only randomized
- [IMI Global Trends in Myopia Management Attitude and Strategies in Clinical Practice – 2025 Update](https://myopiainstitute.org/imi-whitepaper/imi-global-trends-in-myopia-management-attitude-and-strategies-in-clinical-practice-2025-update/) - A range of approaches to myopia management, including behavioural, optical, illumination, and pharmacological strategies, are being actively studied and increasingly adopted in clinical practice. However, there is still no standardized global approach for managing young premyopic or myopic patients, and access to interventions varies widely across regions. Previous global surveys in 2015, 2019, and 2022
- [IMI 2025 Digest](https://myopiainstitute.org/imi-whitepaper/imi-2025-digest/) - Introduction The IMI provides biennial white papers to offer evidence-based consensus guidance that is both scientifically rigorous and clinically practical. The accompanying Digests offer targeted updates on topics from earlier white papers. The 2025 Digest1 presents focused updates in six areas: definitions and classification of myopia, clinical management guidelines, risk factors, accommodation and binocular vision,
- [IMI Myopia Genetics Report](https://myopiainstitute.org/imi-whitepaper/imi-myopia-genetics-report/) - Since the last IMI Genetics Report in 2019, research into the genetics of myopia has expanded rapidly. Thousands of genetic variants are now linked with refractive error, offering new insight into how the eye grows and why some people develop high myopia while others do not. Recent studies confirm that myopia has a strong genetic
- [IMI The Role of Light in Refractive Error Development and Myopia](https://myopiainstitute.org/imi-whitepaper/imi-the-role-of-light-in-refractive-error-development-and-myopia/) - Time spent outdoors has a consistent protective association with delayed myopia onset in children which may be associated with exposure to sunlight. Multiple countries have adopted outdoor time recommendations for children (such as two hours daily), and clinical trials as well as national programs (e.g., Singapore, Taiwan, China) have observed reductions in myopia incidence following
- [IMI Instrumentation for Myopia Management](https://myopiainstitute.org/imi-whitepaper/imi-instrumentation-for-myopia-management/) - Introduction Advancements in instrumentation have enabled clinicians to obtain more accurate and reliable clinical data to guide myopia management and provide individualized evidence-based care for patients.This IMI paper summarizes clinical best practices for the use of instrumentation to assess optical and structural aspects of the eye. Optical Assessment: Refractive Error: Cycloplegic subjective refraction remains
- [IMI 2023 Digest](https://myopiainstitute.org/imi-whitepaper/imi-2023-digest/) - Latest research from topic areas covered in previous IMI white paper series was reviewed by experts and findings summarized in the IMI 2023 digest. Myopia definitions Although the first IMI white paper defining myopia set refractive thresholds as ≤−0.5 D for myopia and ≤−6.0 D for high myopia, the paper also recognised the challenges
- [IMI Global trends in myopia management attitudes and strategies in clinical practice - 2022 Update](https://myopiainstitute.org/imi-whitepaper/imi-global-trends-in-myopia-management-attitudes-and-strategies-in-clinical-practice-2022-update/) - Various approaches to myopia management, including behavioural, optical, and pharmacological methods, are being studied and implemented in clinical practice. However, there is currently no standardized approach to managing young premyopic and myopic patients, and access to these methods can vary depending on location. Despite the high level of concern and self-reported engagement in myopia control
- [IMI Non-Pathological Human Ocular Tissue Changes with Axial Myopia](https://myopiainstitute.org/imi-whitepaper/imi-non-pathological-human-ocular-tissue-changes-with-axial-myopia/) - Background Axial myopia is characterised by an elongated eyeball, which can lead to various structural changes within the eye. This white paper explores the nonpathological ocular changes associated with axial myopia. Changes related to mild to moderate myopia are compared to those with high myopia. The authors utilised histomorphometric and clinical studies to analyse the
- [IMI - The Dynamic Choroid: New Insights, Challenges, and Potential Significance for Human Myopia](https://myopiainstitute.org/imi-whitepaper/imi-the-dynamic-choroid-new-insights-challenges-and-potential-significance-for-human-myopia/) - There is increasing interest in the role the choroid plays in the regulation of eye growth and the potential implications this has on the development and treatment of myopia. What has been learned from animal models? Extensive work has been performed in animal models, guiding and informing what is known about the dynamic nature of
- [IMI Onset and Progression of Myopia in Young Adults](https://myopiainstitute.org/imi-whitepaper/imi-onset-and-progression-of-myopia-in-young-adults/) - Whilst the onset and progression of myopia is usually seen in childhood, it can also occur in adulthood (aged 18 to 40 years). This paper explores the existing evidence around myopia onset, progression, risk factors and management of myopia in adulthood. When does Juvenile-Onset Myopia Stabilize? Data is scarce and there is a great deal
- [IMI Management and Investigation of High Myopia in Infants and Young Children](https://myopiainstitute.org/imi-whitepaper/imi-management-and-investigation-of-high-myopia-in-infants-and-young-children/) - Prevalence of high myopia in infants and young children High myopia in children under 5-6 years of age is rare. In China and Singapore, prevalence rates of 0.03-0.2% have been reported for myopia worse than -6.0D in children under 7 years of age. In the USA, the prevalence of myopia worse than -4.0D has been
- [IMI 2023 White Papers Introduction](https://myopiainstitute.org/imi-whitepaper/imi-2023-white-papers-introduction/) - IMI white papers are published in response to the growing need for consensus and clinical management guidance on the ever growing, and sometimes conflicting, evidence base around myopia development and management. Consolidation, consensus, and updates on all the latest evidence in the form of these white papers is an important resource for practicing clinicians who
- [IMI Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies](https://myopiainstitute.org/imi-whitepaper/defining-and-classifying-myopia/) - Prof. Daniel Flitcroft MB.BS, D.Phil Taskforce Chair IMI Children’s University Hospital, University College Dublin and Dublin Institute of Technology, Ireland INTRODUCTION Myopia is widely recognized as a significant public health issue that has been shown to be a significant cause of visual loss and a risk factor for a range of other serious ocular conditions.
- [IMI Pathologic Myopia](https://myopiainstitute.org/imi-whitepaper/imi-pathologic-myopia/) - Prof. Kyoko Ohno-Matsui MD, PhD Advisory Board & Taskforce Chair IMI Department of Ophthalmology, Tokyo and Medical Dental University, Tokyo, Japan Pathologic myopia is a major cause of visual impairment worldwide and is distinctly different from ‘high myopia’. ‘Pathologic myopia’ is defined by a presence of typical complications in the fundus (posterior staphyloma or myopic
- [IMI Risk Factors for Myopia](https://myopiainstitute.org/imi-whitepaper/imi-risk-factors-for-myopia/) - Prof. Ian Morgan PhD Taskforce Chair IMI Australian National University, Canberra, Australia The prevalence of myopia and high myopia has been increasing in many parts of the world, in particular East and South East Asia. Genetics alone cannot explain the dramatic change over the last fifty years and environmental risk factors have a key role
- [IMI 2021 Yearly Digest](https://myopiainstitute.org/imi-whitepaper/imi-2021-yearly-digest/) - Abstract Purpose: The International Myopia Institute (IMI) Yearly Digest highlights new research considered to be of importance since the publication of the first series of IMI white papers. Methods: A literature search was conducted for articles on myopia between 2019 and mid-2020 to inform definitions and classifications, experimental models, genetics, interventions, clinical trials, and clinical management. Conference
- [IMI Myopia Control Reports Overview and Introduction](https://myopiainstitute.org/imi-whitepaper/imi-myopia-control-reports-overview-and-introduction/) - Abstract With the growing prevalence of myopia, already at epidemic levels in some countries, there is an urgent need for new management approaches. However, with the increasing number of research publications on the topic of myopia control, there is also a clear necessity for agreement and guidance on key issues, including on how myopia should
- [IMI Prevention of Myopia and its Progression](https://myopiainstitute.org/imi-whitepaper/imi-prevention-of-myopia-and-its-progression/) - Prof. Jost B. Jonas MD, PhD Advisory Board & Taskforce Chair IMI Department of Ophthalmology, Heidelberg University, Heidelberg, Germany The prevalence of myopia has markedly increased in East and Southeast Asia, and pathologic consequences of myopia, including myopic maculopathy and high myopia-associated optic neuropathy, are now one of the most common causes of irreversible blindness.
- [IMI Accommodation and Binocular Vision in Myopia Development and Progression](https://myopiainstitute.org/imi-whitepaper/imi-accommodation-and-binocular-vision-in-myopia-development-and-progression/) - Prof. Nicola Logan PhD, MCOptom Taskforce Chair IMI Optometry & Physiological Optics, School of Optometry, Aston University, Birmingham, UK The role of accommodation and binocular vision in myopia development and progression is not fully understood. More recently, the understanding of the mechanisms involved in accommodation and the consequent changes in ocular structures such as the
- [IMI Clinical Management Myopia Guidelines Report](https://myopiainstitute.org/imi-whitepaper/clinical-management-myopia-guidelines-report/) - Dr. Kate L. Gifford PhD, BAppSc (Optom) Taskforce Chair IMI Private Practice and Queensland University of Technology, Brisbane, Australia INTRODUCTION This report details evidence-based best practice for myopia management, including risk factor identification, the examination process, selection of treatment strategies and guidelines for ongoing management. Practitioner considerations such as gaining informed consent and patient and
- [Update and guidance on management of myopia](https://myopiainstitute.org/imi-whitepaper/update-and-guidance-on-management-of-myopia/) - In cooperation with the European Society of Ophthalmology, the International Myopia Institute is please to share the new publication "Update and guidance on management of myopia". Published in the European Journal of Ophthalmology, this new publication will support the awareness of myopia in European settings. Abstract The prevalence of myopia is increasing extensively worldwide. The
- [IMI Clinical myopia control trials and instrumentation report](https://myopiainstitute.org/imi-whitepaper/clinical-myopia-control-trials-and-instrumentation-report/) - Prof. James S. Wolffsohn PhD, FCOptom Advisory Board & Taskforce Chair IMI Ophthalmic Research Group, Aston University, Birmingham, UK INTRODUCTION This report details evidence-based recommendations to guide clinical trial protocols and to inform future instrumentation development, facilitating the improvement and allowing for data comparison across clinical trials. The outcomes were classified as primary (refractive error
- [IMI Industry guidelines and ethical considerations for myopia control](https://myopiainstitute.org/imi-whitepaper/industry-guidelines-and-ethical-considerations-for-myopia-control/) - Prof. Lyndon Jones PhD, FCOptom Taskforce Chair IMI Centre for Ocular Research & Education (CORE), School of Optometry & Vision Science, University of Waterloo, Waterloo, Canada INTRODUCTION Myopia affects approximately 30% of the global population and is predicted to affect 50% by 2050. Increasing levels of myopia are associated with a higher risk of potentially
- [Editorial: Myopia - A 21st Century Public Health Issue](https://myopiainstitute.org/imi-whitepaper/editorial-myopia-a-21st-century-public-health-issue/) - Based on the growing prevalence of myopia around the world, in particular in the young generations in East and Southeast Asia, it was the vision of the late Professor Brien Holden to initiate the International Myopia Institute. For long, Professor Holden, who already had founded and led the Brien Holden Vision Institute in Sydney, had
- [IMI Myopia Genetics Report](https://myopiainstitute.org/imi-whitepaper/myopia-genetics/) - Dr. Milly S. Tedja MD Taskforce Member IMI Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands Prof. Caroline Klaver MD, PhD Taskforce Chair IMI Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands Department of Ophthalmology,
- [IMI Report on Experimental Models of Emmetropization and Myopia](https://myopiainstitute.org/imi-whitepaper/experimental-models-of-emmetropization-and-myopia/) - Prof. Earl L. Smith III OD, PhD Advisory Board & Taskforce Chair IMI College of Optometry, University of Houston, Houston, TX, USA Prof. David Troilo PhD Taskforce Chair IMI SUNY College of Optometry, State University of New York, New York, NY, USA INTRODUCTION This report describes and reviews the major contributions that experimental models of
- [IMI Interventions for Controlling Myopia Onset and Progression Report](https://myopiainstitute.org/imi-whitepaper/interventions-for-myopia-onset-and-progression/) - Prof. Christine F. Wildsoet PhD, DipAppSci (Optom), BSci (Hons Pharm) Advisory Board & Taskforce Chair IMI Berkeley Myopia Research Group, School of Optometry & Vision Science Program, University of California Berkeley, Berkeley, CA, USA INTRODUCTION The published IMI intervention white paper represents a review of the research into myopia-related interventions, organized under four categories: optical,
- [IMI Impact of Myopia](https://myopiainstitute.org/imi-whitepaper/imi-impact-of-myopia/) - Prof. Padmaja Sankaridurg PhD, BOptom Advisory Board & Taskforce Chair IMI Brien Holden Vision Institute, Sydney, Australia School of Optometry and Vision Science, University of New South Wales, Sydney, Australia Myopia is a global health issue affecting almost 30% of the world’s population. By 2050, the prevalence is predicted to rise to 50% globally, 10%
- [IMI 2021 Reports and Digest - Reflection on the Implications for Clinical Practice](https://myopiainstitute.org/imi-whitepaper/imi-2021-reports-and-digest-reflection-on-the-implications-for-clinical-practice/) - Public health is defined as “the art and science of preventing disease, prolonging life and promoting health through the organized efforts of society.”1 Myopia has a major impact on eye health and hence quality of life and disability, particularly later in life, owing to its association with both direct and indirect damage to the chorioretina,

## Ambassadors

- [Min Kim](https://myopiainstitute.org/ambassadors/min-kim/) - Professor and Chief Department of Ophthalmology Gangnam Severance Hospital Yonsei University College of Medicine, Seoul, Korea
- [Kyung Rim Sung](https://myopiainstitute.org/ambassadors/kyung-rim-sung/) - Professor of Department of Ophthalmology University of Ulsan, Asan Medical Center
- [Rasha Altaie](https://myopiainstitute.org/ambassadors/rasha-altaie/) - Rasha is an anterior segment and paediatric ophthalmologist specialist. She finished both her basic and higher surgical training in ophthalmology in Ireland. She obtained her Fellowship in Ophthalmology from the Royal College of Surgeons in Ireland in 2002, and her Master's degree in cataract surgery in 2003. Rasha has been awarded a few national and
- [Jagrut Lallu](https://myopiainstitute.org/ambassadors/jagrut-lallu/) - Jagrut graduated with Honours and a host of undergraduate awards from the University of Auckland in 2009; that same year he began working for Rose Optometry – Home of the Rose K lens, in Hamilton, New Zealand. He has a special interest in irregular cornea, disease and orthokeratology, including Hyperopic, astigmatic and myopia control Ortho-K.
- [Paolo Nucci](https://myopiainstitute.org/ambassadors/paolo-nucci/) - Full Professor of Ophthalmology at the University of Milan, Paolo graduated at Naples University in 1983 and obtained a postgraduate diploma in Ophthalmology in 1988 at the Milan University. The following year completed a Fellowship in Pediatric Ophthalmology and Strabismus at the University of Chicago and, as soon as he returned, he was appointed as
- [Rigmor Baraas](https://myopiainstitute.org/ambassadors/rigmor-baraas/) - Rigmor C. Baraas is a Professor of Optometry & Vision Science and Director of Research for the National Centre for Optics, Vision and Eye Care at the University of South-Eastern Norway, Kongsberg, Norway. Rigmor’s research interests are the development of the eye and refractive errors. This includes the development and aetiology of myopia and the functional implications
- [Silvia Moguel-Ancheita](https://myopiainstitute.org/ambassadors/silvia-moguel-ancheita/) - Strabismologist Ophthalmologist Surgeon Master’s Degree in Neurosciences. Pablo De Olavide University, Spain. Master’s Degree in Research Ethics. “Benemérito De Las Américas” University Award Medical Undergraduate, Naval Health, Navy of Mexico Honor Awards In: Surgeon Career, Professional Examination and Specialty In Ophthalmology. Head Professor of High Specialty In Strabismus. Universidad Autonoma De Mexico Professor of Neurostimulation
- [Francisco Pérez](https://myopiainstitute.org/ambassadors/francisco-perez/) - Francisco Pérez Robles graduated from the School of Optometry (UAL) with honors in 1995. He obtained his master's degree in Diagnostics and Visual Therapeutics at the UAD Campus Laguna in 2014. He has taken different seminars in binocular vision, low vision organized by prestigious universities. He is a professor in the field of binocular vision,
- [Josias Rodriguez](https://myopiainstitute.org/ambassadors/josias-rodriguez/) - Ophthalmic Technician, Pedro Henríquez Ureña University (UN.P.H.U.) and Centro Cristiano De Servicios Médicos (C.C.S.M.) Dominican Republic. Eye Health Promoter. Professor School of Ophthalmic Technicians (Centro Cristiano De Servicios Médicos C.C.S.M.). Special Contact Lenses (Centro Cristiano De Servicios Médicos C.C.S.M.) Dominican Republic. Ambassador Grupo Manejo De Miopía LATAM
- [Xiangui (Hedy) He](https://myopiainstitute.org/ambassadors/xiangui-hedy-he/) - Dr. Xiangui (Hedy) He is the director of the Clinical Research Center of Shanghai Eye Disease Prevention and Treatment Center/Shanghai Eye hospital, and executive director of Shanghai Children Myopia Center. She also supervises Master's students at Shanghai Jiao Tong University and Fudan University. She has implemented the large-scale (3 million) vision screening program for children
- [Mukharram Bikbov](https://myopiainstitute.org/ambassadors/mukharram-bikbov/) - Professor Mukharram M. Bikbov is a comprehensive ophthalmologist and clinical scientist, director of Ufa Eye Research Institute. Professor Bikbov is Senior Vice-President of the Russian Ophthalmology Society, Honored physician of the Russian Federation, Chief Ophthalmologist of the Ministry of Health of the Republic of Bashkortostan, Honorary Professor of FSBI "Scientific-research Institute of eye diseases", Corresponding
- [Angel Macedo Mariano](https://myopiainstitute.org/ambassadors/angel-macedo-mariano/) - Angel Macedo Mariano obtained the degree of Optometrist at the Universidad Peruana Los Andes, followed by pursuing a career as a Medical Technologist at the same university. Mg Macedo holds a Master's degree in Health Services Administration at the Universidad Federico Villareal, is a Fellow in Public Health from the Inter American University of Puerto
- [Pavan Verkicharla](https://myopiainstitute.org/ambassadors/pavan-verkicharla/) - Dr Pavan Verkicharla is the Scientist researching on both basic and transnational aspects of myopia at the Myopia Research Lab in L V Prasad Eye Institute, India. Pavan pursued his PhD from the Queensland University of Technology, Australia and post-doctoral research from Singapore Eye Research Institute, Singapore. He has numerous publications in international peer-reviewed journals and is passionate about myopia research. He also serves as a reviewer
- [Huy Tran](https://myopiainstitute.org/ambassadors/huy-tran/) - Huy Tran is Medical Director and Head of Research Department of Hai Yen Eye Care, Lecturer and Assistant Head of Residency Program of Ophthalmology Department, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Visiting Lecturer of the Optometry Department, Pham Ngoc Thach Medical University, Ho Chi Minh City, Vietnam. Huy is certified as an ophthalmologist
- [Elena Tarutta](https://myopiainstitute.org/ambassadors/elena-tarutta/) - Elena Tarutta is an experienced ophthalmologist and clinical scientist, head of the Department of Refraction Pathology, Binocular Vision and Ophthalmoergonomics of the Helmholtz National Medical Research Center, Moscow, Russia. Obtained her Ph.D. in ophthalmology from Moscow Helmholtz Research Institute for Eye Diseases in 1981 (thesis: “New sclera reinforcement surgery and its results in high myopia”).
- [Elena Iomdina](https://myopiainstitute.org/ambassadors/elena-iomdina/) - Elena Iomdina is a Principal Researcher of the Department of Refraction Pathology, Binocular Vision and Ophthalmoergonomics at Helmholtz National Medical Research Center of Eye Diseases, Moscow, Russia. Obtained her Ph.D. in biology from Moscow Helmholtz Research Institute for Eye Diseases in 1985 (thesis: “Biomechanical Properties of Sclera and Methods of its Reinforcement in Myopia”). Doctoral
- [Uğur Emrah Altiparmak](https://myopiainstitute.org/ambassadors/ugur-emrah-altiparmak/) - Prof. Uğur Emrah Altıparmak, MD, FICO is a graduate of Hacettepe University Medical School Ankara, Turkey. Dr. Altiparmak trained as a resident in the Ministry of Health Ankara Research and Training Hospital, Ankara, Turkey. During his residency, he followed a mini-fellowship at Meir Hospital, Tel-Aviv University, School of Medicine, with emphasis on Anterior Segment diseases
- [Luisa Casas Luque](https://myopiainstitute.org/ambassadors/luisa-casas-luque/) - Dr. Luisa Casas Luque is a Colombian Optometrist (OD, Phd, Magna cum laude in Education and Society from La Salle University. She has worked in public hospitals and private practice and completed post graduate studies at Pennsylvania College of Optometry in clinical diagnosis and management of ocular disease, worked for two years at Durban Westville
- [Giancarlo Montani](https://myopiainstitute.org/ambassadors/giancarlo-montani/) - Giancarlo Montani Optometrist FBCLA is Professor of Clinical Contact Lens Application at the University of Salento, Italy. Involved in Optometry education since 1988, he has been Department Head of the Contact Lens Division at the Santa Chiara University Medical Centre in Pisa, Italy until 2004. In 2007 Professor Giancarlo Montani has co-founded the Centre for
- [Elena García Rubio](https://myopiainstitute.org/ambassadors/elena-garcia-rubio/) - Elena García Rubio, (Madrid 1971), attended her first congress of optometry and contact lenses at age 16, there she discovered her future and graduated from Optometry School in Madrid (1994), completed a Master degree in Optometry, Contact Lenses and Vision Therapy at the Centro de Optometría Internacional in Madrid (1995). Completed her optometry education in
- [Nicola Logan](https://myopiainstitute.org/ambassadors/nicola-logan/) - Nicola is a Professor of Optometry and Director of Research for the Optometry and Vision Science Research Group, School of Optometry, Aston University, Birmingham, UK. Nicola’s research interests are the epidemiology of refractive error, the development and aetiology of myopia, and strategies for myopia control. Nicola leads an active myopia clinic at Aston University alongside
- [Charlie L. Ho](https://myopiainstitute.org/ambassadors/charlie-l-ho/) - Dr. Charlie Ho, is the Chairman of the Board and a four-term national president of the Integrated Philippine Association of Optometrists (IPAO). He is the founding President of the Vision Science Institute, which was organized to give optometrists opportunity for post-graduate specialty training. He is a member of the Career Progression and Specialization (CPSP) Committee for Optometry of the
- [Rafael Iribarren](https://myopiainstitute.org/ambassadors/rafael-iribarren/) - Dr Rafael Iribarren is an Ophthalmologist specialising in refractive errors, with a keen interest in improving the understanding of the principal causes of need for refractive correction (myopia, hyperopia and presbyopia). Rafael has performed prevalence studies of refractive error in Argentina, and has collaborated in the calculation of crystalline lens power for studies in countries around
- [Edson dos Santos-Neto](https://myopiainstitute.org/ambassadors/edson-dos-santos-neto/) - Dr Edson dos Santos-Neto has a degree in medicine from the Faculty of Medicine of the University of São Paulo and a fellowship in ophthalmology from the Hospital das Clínicas of São Paulo and graduated specialist in the area of contact lenses and pediatric ophthalmology. For 35 years he has been an associate physician at
- [Kyoko Ohno-Matsui](https://myopiainstitute.org/ambassadors/kyoko-ohno-matsui/) - Kyoko Ohno-Matsui is Professor and Chairperson of the Department of Ophthalmology and Visual Science at Tokyo Medical and Dental University (TMDU), and the Chief of the Advanced Clinical Center for Myopia at TMDU. Dr. Ohno-Matsui has been the recipient of Young Investigator Award in Japanese Ophthalmological Society and the Excellence in Research Award at TMDU.
- [Irina Smirnova](https://myopiainstitute.org/ambassadors/irina-smirnova/) - Professor Irina Smirnova is a paediatric ophthalmologist, candidate of Medical Sciences, teacher, director of the Siberian Ophthalmological Center "Glazka", and head of the Siberian Association of Pediatric Ophthalmologists. With 40 years experience, Irena specialises in progressive myopia in children. Irena is the author of a landmark epidemiological study on the prevalence of refractive disorders in 28,700
- [Maria Marta Galan](https://myopiainstitute.org/ambassadors/maria-marta-galan/) - Dr. Maria Marta Galan trained in the Specialty of Pediatric Ophthalmography at the Santa Maria Ludovica Children's Hospital in La Plata, eventually becoming the Head of the Hospital. Maria rotated at the Juan P. Garraham National Pediatric Hospital (Argentina), at the Ricardo Gutierrez Children's Hospital in Buenos Aires (Argentina) and at the Kosair Children's Hospital in
- [Dwight Akerman](https://myopiainstitute.org/ambassadors/dwight-akerman/) - Dr. Dwight Akerman serves as the Chief Medical Editor at Review of Myopia Management, the world's most widely subscribed myopia journal. He is an internationally recognized senior healthcare leader with extensive experience in myopia management, peer education & communications, medical marketing, innovation, financial management, and M&A/business development & licensing. Dr. Akerman was the Vice President
- [Klaus Trier](https://myopiainstitute.org/ambassadors/klaus-trier/) - Dr. Klaus Trier is MD from University of Copenhagen 1983, qualified as eye specialist in 1990, and was chief eye surgeon at Frederiksberg Hospital 1993-97. In 1993 he founded Trier Research Laboratories. Dr. Trier is author of scientific articles and a textbook chapter about connective tissue, the sclera, and myopia, and has been invited as
- [Weizhong Lan](https://myopiainstitute.org/ambassadors/weizhong-lan/) - Dr. Weizhong Lan is a full professor in Central South University, China and the vice director of Aier Institute of Optometry and Vision Science, Aier EYE Hospital Group. He finished his clinical training as an Ophthalmologist in Zhongshan Ophthalmic Center (China) and achieved his M.D / Ph.D of Neuroscience in University of Tuebingen (Germany). His main
- [Pei-Chang Wu](https://myopiainstitute.org/ambassadors/pei-chang-wu/) - Professor Pei-Chang Wu is director of Myopia Treatment and Prevention Center (Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital), professor at Chang Gung University, supervisor of the Ophthalmological Society of Taiwan (Chinese Taipei), director of Taiwan Retina Society (Chinese Taipei), consultant for Health Promotion Administration in Ministry of Health and Welfare K-12 Education Administration in
- [Maria Liu](https://myopiainstitute.org/ambassadors/maria-liu/) - Dr. Maria Liu is an associate professor at UC Berkeley School of Optometry, and the founder of the Myopia Control Clinic of UC Berkeley Eye Center. She received her bachelor degree of clinical medicine from Peking University, her OD from Pacific University, her PhD and MPH from UC Berkeley. She is a world renowned clinical
- [Patricia Ioschpe Gus](https://myopiainstitute.org/ambassadors/patricia-ioschpe-gus/) - Graduate in Medicine at Universidade Federal do Rio Grande do Sul, PhD in Ophthalmology at Universidade de São Paulo, fellowship in Refractive Surgery at Universidade Federal de São Paulo - Escola Paulista de Medicina and in Hospital Management at Escola de Saúde Pública da Fundação Oswaldo Cruz (ENSP/Fiocruz), obtained the Medical Doctor's Degree by Ordem
- [Minh Anh Tran](https://myopiainstitute.org/ambassadors/minh-anh-tran/) - Ms. Minh Anh Tran is one of the first optometrists in Vietnam. She received her Bachelor of Optometry at Bausch and Lomb School of Optometry, India - (L.V. Prasad) in 2013. Subsequently, in 2015, she has graduated from Melbourne University with a master’s degree in clinical optometry. Together with local partners, Ms. Minh Anh developed the
- [Edgar Dávila-García](https://myopiainstitute.org/ambassadors/edgar-davila-garcia/) - Doctor of Optometry, graduated from the Inter American University School of Optometry in 1996. He is Diplomate of the National Board of Examiners in Optometry with licenses to practice Optometry in Puerto Rico and Texas, USA. He maintains a practice specialized in contact lenses, dry eye, refractive technologies, and more recent myopia management. Dr. Dávila-García
- [Sotiris Plainis](https://myopiainstitute.org/ambassadors/sotiris-plainis/) - Sotiris Plainis completed his undergraduate studies in Optics and Optometry in Greece and UK, respectively. These were followed by postgraduate (MSc, 1995; PhD, 1999) and postdoctoral (1999-2001) research at the Department of Optometry and Vision Sciences, UMIST, UK. Since then he has been employed as Principal Research Fellow at the Laboratory of Optics and Vision
- [Stephanie Ramdass](https://myopiainstitute.org/ambassadors/stephanie-ramdass/) - Dr. Stephanie Ramdass is in clinical practice in Toronto and Mississauga, Ontario, Canada. She graduated from the Inter American University of Puerto Rico School of Optometry and completed a cornea and contact lens residency at the Michigan College of Optometry. Dr. Ramdass is a member of the Ontario Association of Optometrists, and fellow of the American
- [Ariolfo G. Vazquez](https://myopiainstitute.org/ambassadors/ariolfo-g-vazquez/) - Ariolfo G. Vazquez is an Ecuador based optometrist and co-founder of the LATAM Myopia Management Group. A specialist in contactology, special lenses and myopia management, Dr Vazquez is Head of the Department of Contactology and Optometry, at Oftalmolaser Clinic, Cuenca-Ecuador, and Manager and owner of Centro Visual, Optocentro, Cuenca-Ecuador). Dr Vazquez is the Speaker for
- [Jost Jonas](https://myopiainstitute.org/ambassadors/jost-jonas/) - Professor Jost Jonas is a comprehensive ophthalmologist and clinical scientist, chairman of the Department of Ophthalmology/Heidelberg University/Germany, member of the German Academy of Science, Glaucoma Research Society, Macula Society, Retina Society, and Academia Ophthalmologica Internationalis. In addition, Professor Jonas is honorary Member of the French Ophthalmological Society and Asia-Pacific Vitreoretinal Society, and received the International
- [Arnaud Sauer](https://myopiainstitute.org/ambassadors/arnaud-sauer/) - Arnaud Sauer is Professor of Ophthalmology at Strasbourg University Hospital, France. Professor Sauer specialises in surgical and medical ophthalmopediatrics, as well as strabismus care, and is author of over 80 publications indexed on Pubmed in the fields of pediatric ophthalmology, immune regulation of eye infections, functional improvements (reading abilities, driving skills) induced by strabismus surgery, digital eye

## Downloads

- [Facts & Findings - Swedish](https://myopiainstitute.org/download/11570/?tmstv=1790048462)
- [Facts & Findings - Arabic](https://myopiainstitute.org/download/32107/?tmstv=1790048462)
- [Facts & Findings - Portuguese](https://myopiainstitute.org/download/32101/?tmstv=1790048462)
- [Facts & Findings - Japanese](https://myopiainstitute.org/download/10577/?tmstv=1790048462)
- [Facts & Findings - Hebrew](https://myopiainstitute.org/download/32092/?tmstv=1790048462)
- [Facts & Findings - German](https://myopiainstitute.org/download/10589/?tmstv=1790048462)
- [Facts & Findings - Russian](https://myopiainstitute.org/download/11563/?tmstv=1790048462)
- [Facts & Findings Dutch](https://myopiainstitute.org/download/13740/?tmstv=1790048462)
- [Facts & Findings - Spanish](https://myopiainstitute.org/download/10591/?tmstv=1790048462)
- [Japanese_IMI_Myopia_Infographic_2Page](https://myopiainstitute.org/download/31621/?tmstv=1790048462)
- [BHVI-IRA-Flowcharts-MAR2025](https://myopiainstitute.org/download/31601/?tmstv=1790048462)
- [Facts & Findings - Chinese Traditional](https://myopiainstitute.org/download/10579/?tmstv=1790048462)
- [Facts & Findings - Chinese Simplified](https://myopiainstitute.org/download/10581/?tmstv=1790048462)
- [Facts & Findings - Italian](https://myopiainstitute.org/download/25932/?tmstv=1790048462)
- [Facts & Findings - Vietnamese](https://myopiainstitute.org/download/25929/?tmstv=1790048462)
- [Facts & Findings - English](https://myopiainstitute.org/download/10575/?tmstv=1790048462)
- [Facts & Findings - Greek](https://myopiainstitute.org/download/10583/?tmstv=1790048462)
- [Facts & Findings - Spanish (old)](https://myopiainstitute.org/download/9792/?tmstv=1790048462)
- [Facts & Findings - Turkish](https://myopiainstitute.org/download/11568/?tmstv=1790048462)
- [Facts & Findings - French](https://myopiainstitute.org/download/10587/?tmstv=1790048462)
- [Consensus for the myopia management in the age of progression](https://myopiainstitute.org/download/20411/?tmstv=1790048462)
- [Facts and Findings Infographic](https://myopiainstitute.org/download/9731/?tmstv=1790048462)
- [IMI 2021 - Greek Translation Booklets - Modern Optical (Σύγχρονη Οπτική)](https://myopiainstitute.org/download/12159/?tmstv=1790048462)
- [IMI 2019 - Greek Translation Booklets - Modern Optical (Σύγχρονη Οπτική)](https://myopiainstitute.org/download/12155/?tmstv=1790048462)
- [IMI 2021 - Dutch Booklet](https://myopiainstitute.org/download/12151/?tmstv=1790048462)
- [IMI 2021 - Spanish Review Series](https://myopiainstitute.org/download/12148/?tmstv=1790048462)

## Events

- [Webinights German Optometric Conference](https://myopiainstitute.org/events/webinights-german-optometric-conference/) - IMI Executive Director Dr Monica Jong joins Stefan Lahme and Peter Bruckmann to discuss putting myopia management into practice or WebiNights (GER). Attended by ~400 eye care practitioners, you can view the session here: webinights.ch.
- [WCO Myopia Management Webinar](https://myopiainstitute.org/events/wco-myopia-management-webinar/) - IMI Executive Director Dr Monica Jong and Taskforce Leader Professor Ian Flitcroft, along with committee members Dr Maria Liu and Dr Fuensanta Vera-Diaz, and fellow panellists Indie Grewal and Matt Oerding, recently participated in an expert panel discussion on myopia management with the World Council of Optometry. View the panel discussion below, as these experts help navigate
- [Cornea & Contact Lens Society of Australia WA Masterclass](https://myopiainstitute.org/events/cornea-contact-lens-society-of-australia-wa-masterclass/) - Why talk about Dry Eye, Myopia and Toric RGPs? Three seemingly unrelated fields are becoming ever more intertwined in our everyday patient management. Learning Objectives: Understanding myopia control is important, but having an arsenal of treatment options to control it, is just as necessary. Understanding toric RGPs is a necessary step in understanding how to
- [e-International Optometry & Vision Science Conference 2021](https://myopiainstitute.org/events/e-international-optometry-vision-science-conference-2021/) - The e-IOVIC 2021 is intended to be the first co-organized, online international conference on optometry and vision science in Malaysia. IMI Chair and Advisory Board Member, Professor James Wolffsohn will be delivering a keynote session on Diagnosing an Managing Dry Eye. IMI Executive Director Dr Monica Jong will deliver a plenary session on Myopia: A global public health
- [ARVO Virtual Meeting: Are we being myopic about myopia? Updated evidence for a change in clinical practice.](https://myopiainstitute.org/events/arvo-virtual-meeting-are-we-being-myopic-about-myopia-updated-evidence-for-a-change-in-clinical-practice/) - The first meeting introducing the key findings of the IMI 2021 white papers with a focussed panel discussion on what the implications are for clinical practice and myopia research. The chairs of the IMI 2021 taskforces Professors Kyoko Ohno-Matsui, Jost B. Jonas, Padmaja Sankaridurg, Nicola Logan and Ian Morgan will be discussing the areas of pathologic myopia, prevention
- [Dr. Monica Jong at Cake & Pie Expo](https://myopiainstitute.org/events/dr-monica-jong-at-cake-pie-expo/) - Dr. Monica Jong will be delivering a session on ‘Myopia – a call to action’ as part of the ORBIS Singapore Session: The Myopia Epidemic in Asia Pacific at the Cake & Pie Expo.
- [Vision Expo's EYE2EYE Series to Cover Childhood Myopia Pandemic](https://myopiainstitute.org/events/vision-expos-eye2eye-series-to-cover-childhood-myopia-pandemic/) - “Proactively Managing the Childhood Myopia Pandemic” will be presented Wednesday, Aug. 25 at 7pm Eastern as part of Vision Expo’s EYE2EYE series. The growing prevalence of childhood myopia mandates that eye care practitioners have a thorough understanding of managing myopia proactively. This panel discussion will cover available and future interventions for controlling myopia progression, evidence
- [Unravelling Myopia With India Vision Institute](https://myopiainstitute.org/events/unravelling-myopia-with-india-vision-institute/) - ABOUT Myopia is a growing public eye health problem and it has been estimated that by 2050, globally 50% population will have myopia. Worldwide, scientists and clinicians are collaboratively involved in developing treatment strategies to control the progression of myopia. The purpose of the lecture series is to educate and update eye health care professionals
- [International Myopia Conference 2022](https://myopiainstitute.org/events/international-myopia-conference-2022/) - ABSTRACT SUBMISSION DEADLINE EXTENSION FOR THE 2022 INTERNATIONAL MYOPIA CONFERENCE From September 4-7, 2022, the 18th International Myopia Conference will be held in Rotterdam, the Netherlands. This is the largest international myopia convention, bringing together vision and basic scientists, clinical experts, as well as policy makers. It will incorporate research from bench to bedside and
- [IMI at 36th Annual APAO Congress](https://myopiainstitute.org/events/imi-at-36th-annual-apao-congress/) - Join Dr. Monica Jong, Professor Padmaja Sankaridurg, Professor Kyoko Ohni-Matsui, Professor Ian Morgan, Professor Jost Jonas, Professor Pei-Chang Wu and Professor Tien Wong, as they discuss the IMI 2021 White Papers covering: Impact of Myopia Pathologic Myopia Risk Factors for Myopia Prevention of Myopia and Its Progression Atropine, Public Health Initiatives and Implementation of Prevention
- [I Curso online: Control Miopia](https://myopiainstitute.org/events/i-curso-online-control-miopia/)
- [13° convegno internazionale su aggiornamenti di contattologia e ottica oftalmica](https://myopiainstitute.org/events/13-convegno-internazionale-su-aggiornamenti-di-contattologia-e-ottica-oftalmica/) - IMI Ambassador Giancarlo Montani and IMI Executive Director Monica Jong, will be delivering sessions at the 13th International Conference on Contactology and Ophthalmic Optics Updates. 9.00 – 9.20 – Common Beliefs Relating to Myopia Not Supported by Scientific Evidence Dr Monica Jong, PhD BOptom 10.00-10.20 Indicators for Choosing Optical Treatments vs Pharmacological Treatment for the Control
- [IMI at American Academy of Optometry 2021](https://myopiainstitute.org/events/imi-at-american-academy-of-optometry-2021/) - About Myopia is one of the greatest public health eye issues of the 21 st century,(1) with 50% of the world’s population predicted to be affected by 2050,(2) when myopia macular degeneration will also join the leading causes of vision impairment. The International Myopia Institute (IMI), a key outcome of a 2015 meeting of the
- [7th WGA Global Webinar on Glaucoma and Myopia](https://myopiainstitute.org/events/7th-wga-global-webinar-on-glaucoma-and-myopia/) - The World Glaucoma Association is inviting you to join the first WGA Global Webinar of 2022, diving into Glaucoma and Myopia. This free, highly educative session will be held on Saturday, February 12, 2022.
- [Launch of the WHO-ITU Be He@lthy, Be Mobile toolkit for myopia (mMyopia)](https://myopiainstitute.org/events/launch-of-the-who-itu-be-helthy-be-mobile-toolkit-for-myopia-mmyopia/) - Myopia is the most common refractive error globally, affecting an estimated 2.6 billion people in 2020. Health promotion and education play a vital role in the prevention of high myopia and its associated complications, while also raising awareness of good eye health behaviours and addressing common reasons for non-compliance to spectacle wear. In the context
- [Virtual Perspective 2022](https://myopiainstitute.org/events/virtual-perspective-2022/) - Cooper Vision is inviting you to join a day filled with evidence-based presentations and panel discussions on myopia management. IMI Taskforce Leaders and Advisory Board members Professor Padmaja Sankaridurg, Professor James Wolffsohn, Professor Kyoko Ohno-Matsui, Professor Ian Morgan and IMI project director Rebecca Weng will be delivering sessions on Public Health Impact of Myopia, Reflections
- [LC Blandos y Orto K en el manejo de la Miopía](https://myopiainstitute.org/events/lc-blandos-y-orto-k-en-el-manejo-de-la-miopia/) - Register for this Spanish myopia management course using contact lens option. It has seven modules including introduction to orthokeratology, Corneal topography, Troubleshooting Orthokeratology, Soft contact lenses for myopia management and Clinical cases for discussion.

## Categories

- [Uncategorized](https://myopiainstitute.org/category/uncategorized/)
- [Myopia Conference](https://myopiainstitute.org/category/myopia-conference/)
- [News](https://myopiainstitute.org/category/news/)
- [Events](https://myopiainstitute.org/category/events/)
- [IMI Series 1](https://myopiainstitute.org/category/imi-series-1/) - IMI Series 1 White Papers & Clinical Summaries
- [IMI Series 2](https://myopiainstitute.org/category/imi-series-2/) - IMI Series 2 White Papers & Clinical Summaries
- [IMI Series 3](https://myopiainstitute.org/category/imi-series-3/)
- [IMI Series 4](https://myopiainstitute.org/category/imi-series-4/)

## Regions

- [Asia-Pacific, Oceania](https://myopiainstitute.org/region/asia-pacific-oceania/)
- [Middle East, Africa](https://myopiainstitute.org/region/middle-east-africa/)
- [Europe](https://myopiainstitute.org/region/europe/)
- [North America](https://myopiainstitute.org/region/north-america/)
- [Latin America](https://myopiainstitute.org/region/latin-america/)

## Download Tags

- [Infographic](https://myopiainstitute.org/?dlm_download_tag=infographic)